Compare HQI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HQI | LAB |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | United States | United States |
| Employees | 75000 | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.1M | 271.0M |
| IPO Year | 2008 | 2008 |
| Metric | HQI | LAB |
|---|---|---|
| Price | $20.22 | $0.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $1.35 |
| AVG Volume (30 Days) | 14.9K | ★ 1.4M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ 73.08 | 61.54 |
| EPS | ★ 0.31 | 0.26 |
| Revenue | $30,640,000.00 | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.46 | $2.63 |
| P/E Ratio | $60.48 | ★ $2.86 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.38 | $0.63 |
| 52 Week High | $19.01 | $1.72 |
| Indicator | HQI | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 75.89 | 51.35 |
| Support Level | $12.14 | $0.70 |
| Resistance Level | N/A | $1.02 |
| Average True Range (ATR) | 0.76 | 0.04 |
| MACD | 0.25 | 0.01 |
| Stochastic Oscillator | 94.26 | 57.88 |
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.